GRL-0617
CAY-33348-5 5 mg
Data Sheet: 
SDS:
SDS:
CAS
1093070-16-6
Formulation
A crystalline solid
Purity
≥98%
MW
304,38568
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
A SARS-CoV and SARS-CoV-2 PLpro inhibitor (IC50s = 0.6 and 1.5 µM, respectively); increases the viability of SARS-CoV-infected Vero E6 cells (EC50 = 14.5 µM); reduces viral replication in SARS-CoV-2-infected Caco-2 cells from 6.25-50 µM
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
